Internal Server Error

EmbarkNeuro - About the company

EmbarkNeuro is an unfunded company based in Oakland (United States), founded in 2021 by Mark Fishman and Joe Jimenez. It operates as a Developer of therapeutics for the treatment of mental health disorders. EmbarkNeuro has not raised any funding yet. The company has 4 active competitors, including 1 funded and 2 that have exited. Its top competitors are Tonix Pharma, Draigtherapeutics and Naurex.

Company Details

Developer of therapeutics for the treatment of mental health disorders. The company is focusing on identifying depressed individuals with a potential biomarker linked to the stress response system and developing ANC-501 for patients with Depression.
Social
X
Email ID
*****@embarkneuro.com
Phone Number
+1 **********
Part Of
Key Metrics
Founded Year
2021
Location
Oakland, United States
Stage
Unfunded
Ranked
Similar Companies
Sign up to download EmbarkNeuro's company profile

EmbarkNeuro's funding and investors

EmbarkNeuro has not raised any funding rounds yet.

EmbarkNeuro's founders and board of directors

Founder? Claim Profile
The founders of EmbarkNeuro are Mark Fishman and Joe Jimenez. Stephen Kanes is the CEO of EmbarkNeuro.
Here are the details of EmbarkNeuro's key team members:
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

EmbarkNeuro's Competitors and alternates

Top competitors of EmbarkNeuro include Tonix Pharma, Draigtherapeutics and Naurex. Here is the list of Top 10 competitors of EmbarkNeuro, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Tonix Pharma
Tonix Pharma
2007, New York City (United States), Public
Developer of next-generation medicines for CNS and immunological disorders
$4.45M
67/100
2nd
Logo for Draigtherapeutics
Draigtherapeutics
2021, Cardiff (United Kingdom), Series B
Developer of targeted neuromodulators for neuropsychiatric disorders treatment
$205M
60/100
3rd
Logo for Naurex
Naurex
2008, Evanston (United States), Acquired
Clinical-stage company developing novel therapies for depression and other CNS disorders.
$162M
46/100
4th
Logo for EmbarkNeuro
EmbarkNeuro
2021, Oakland (United States), Unfunded
Developer of therapeutics for the treatment of mental health disorders
-
-
28/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on EmbarkNeuro's competitors? Click here to see the top ones

EmbarkNeuro's Investments and acquisitions

EmbarkNeuro has made no investments or acquisitions yet.

Reports related to EmbarkNeuro

Here is the latest report on EmbarkNeuro's sector:

News related to EmbarkNeuro

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about EmbarkNeuro

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford